| 30.75 Data as of May 24 |  -0.46 / -1.47%Today’s Change | 18.29 Today|||52-Week Range 32.86 | +7.41% Year-to-Date |
| July Options Now Available For Bio-Reference Laboratories (BRLI) May 20 / TheStreet.com | Whatbs Going On At Bio-Reference Labs? May 15 / StockTwits |
| Previous close | 31.21 |
| Today’s open | 31.10 |
| Day’s range | 30.48 - 31.36 |
| Volume | 279,630 |
| Average volume (3 months) | 397,608 |
| Market cap | $852.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +17.05% |
| Earnings growth (this year) | +17.71% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +18.44% |
| P/E ratio | 19.8 |
| Price/Sales | 1.16 |
| Price/Book | 3.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| EXELExelixis Inc | -0.03 | -0.63% |
| NXTMNxstage Medical Inc | +0.27 | +1.99% |
| AMRNAmarin Corporation P... | -0.14 | -2.02% |
| KERXKeryx Biopharmaceuti... | 0.00 | 0.00% |
| Next reporting date | June 6, 2013 |
| EPS forecast (this quarter) | $0.41 |
| Annual revenue (last year) | $661.7M |
| Annual profit (last year) | $42.2M |
| Net profit margin | 6.37% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman, President & Chief Executive Officer Marc D. Grodman, MD |
Chief Operating Officer, Director & Executive VP Howard Dubinett |
Corporate headquarters Elmwood Park, New Jersey |
.
